Bioinformatics Platforms Market Drivers
Increasing focus of key players on accelerating drug discovery and development process is expected to aid in the bioinformatics platforms market growth. Pharmaceutical companies, non-profit organizations, and healthcare regularity organizations are increasingly utilizing funds and their capabilities in drug discovery and development process. Growing focus by these players in leveraging bioinformatics platforms for increasing the effectiveness in drug discovery and development process is expected to propel growth of the bioinformatics platforms market.
Various government funding initiatives such as Innovate UK and Horizon 2020 offer businesses and research organizations with grants to help in driving their scientific research. Innovate UK is the UK’s innovation agency and part of UK Research and Innovation. The program supported two companies, Adorial Pharma Limited and C4X Discovery for the development of a novel mathematical-based system of drug discovery.
Moreover, major players in the market are focused on adopting organic and in-organic growth strategies to expand their market presence. For instance, in April 2014, Dassault Systemes, a 3DEXPERIENCE company that develops 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, acquired Accelrys, Inc. Moreover, in May 2014, Dassault Systemes launched BIOVIA with integration of 3DEXPERIENCE technologies from Dassault Systemes and life sciences & material sciences applications from Accelrys. BIOVIA is a software company which provides scientific enterprise software for chemical, materials and bioscience research for pharmaceutical, biotechnology, consumer packaged goods, aerospace, energy and chemical industries.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients